Search

Human urine can be processed into market-attractive fertilizers like struvite; however, concerns regarding the microbial safety of such products remain. The present study evaluated the inactivation of in situ heterotrophs, total bacteria as observed by flow cytometry, and inoculated Enterococcus spp. and Salmonella typhimurium during the drying of struvite under controlled temperature (from 5 to 35 °C) and relative humidity (approximately 40 and 80%) as well as dynamic field conditions. Bacteria accumulated in the struvite cake during struvite filtration. Despite the use of sublethal temperatures, all bacteria types were subsequently inactivated to some degree during struvite drying, and the inactivation typically increased with increasing drying temperature for a given relative humidity. Heterotrophic bacteria inactivation mirrored the trend in total bacteria during struvite drying. A linear relationship was observed between inactivation and sample moisture content. However, bacteria survivor curves were typically nonlinear when struvite was dried at low relative humidity, indicating bacterial persistence. Weibull model survivor curve fits indicated that a shift in the mechanism of inactivation may occur with changing humidity. For increased efficiency of bacterial inactivation during the production of struvite, initial heating under moist conditions is recommended followed by desiccation.

Struvite is a solid phosphorus fertilizer that can be recovered easily from source-separated urine by dosing it with a soluble form of magnesium. The process is simple and low-cost, however, previous studies have shown that the cost of magnesium in low-income countries is crucial to the viability and implementation of struvite precipitation. Literature has proposed producing inexpensive magnesium locally by making magnesium oxide from magnesite. This paper aimed to investigate whether process requirements, costs, and environmental impacts would make this process viable for magnesium production in decentralized settings. Magnesite samples were calcined at temperatures between 400 °C and 800 °C and for durations between 0.5 h and 6 h. The release of magnesium was tested by dissolution in phosphate-depleted urine. The optimal processing conditions were at 700 °C for 1h: magnesite conversion was incomplete at lower temperatures, and the formation of large crystallites caused a decrease in solubility at higher temperatures. The narrow optimal range for magnesium production from magnesite requires reliable process control. Cost estimations for Nepal showed that using local magnesite would provide the cheapest source of magnesium and that CO2 emissions from transport and production would be negligible compared to Nepal's overall CO2 emissions., (Copyright © 2015 Elsevier B.V. All rights reserved.)

Source-separated urine contains most of the excreted nutrients, which can be recovered by using nitrification to stabilize the urine before concentrating the nutrient solution with distillation. The aim of this study was to test this process combination at pilot scale. The nitrification process was efficient in a moving bed biofilm reactor with maximal rates of 930 mg N L(-1) d(-1). Rates decreased to 120 mg N L(-1) d(-1) after switching to more concentrated urine. At high nitrification rates (640 mg N L(-1) d(-1)) and low total ammonia concentrations (1,790 mg NH4-N L(-1) in influent) distillation caused the main primary energy demand of 71 W cap(-1) (nitrification: 13 W cap(-1)) assuming a nitrogen production of 8.8 g N cap(-1) d(-1). Possible process failures include the accumulation of the nitrification intermediate nitrite and the selection of acid-tolerant ammonia-oxidizing bacteria. Especially during reactor start-up, the process must therefore be carefully supervised. The concentrate produced by the nitrification/distillation process is low in heavy metals, but high in nutrients, suggesting a good suitability as an integral fertilizer.

Human urine has the potential to be a sustainable, locally and continuously available source of nutrients for agriculture. Phosphate can be efficiently recovered from human urine in the form of the mineral struvite (MgNH4PO4·6H2O). However, struvite formation may be coupled with the precipitation of other constituents present in urine including pathogens, pharmaceuticals, and heavy metals. To determine if struvite fertilizer presents a microbiological health risk to producers and end users, we characterized the fate of a human virus surrogate (phage ΦX174) and the eggs of the helminth Ascaris suum during a low-cost struvite recovery process. While the concentration of phages was similar in both the struvite and the urine, Ascaris eggs accumulated within the solid during the precipitation and filtration process. Subsequent air-drying of the struvite filter cake partially inactivated both microorganisms; however, viable Ascaris eggs and infective phages were still detected after several days of drying. The infectivity of both viruses and eggs was affected by the specific struvite drying conditions: higher inactivation generally occurred with increased air temperature and decreased relative humidity. On a log-log scale, phage inactivation increased linearly with decreasing moisture content of the struvite, while Ascaris inactivation occurred only after achieving a minimum moisture threshold. Sunlight exposure did not directly affect the infectivity of phages or Ascaris eggs in struvite cakes, though the resultant rise in temperature accelerated the drying of the struvite cake, which contributed to inactivation., (Copyright © 2011 Elsevier Ltd. All rights reserved.)

Urine has great potential to be an effective fertilizer due to its high nutrient content, however, it can contain potentially worrying pharmaceuticals. Our objective was to study whether urine storage and aerobic biological treatment, i.e. nitrification, was sufficient to remove pharmaceuticals or an additional treatment with activated carbon was necessary to produce a fertilizer from urine. We investigated the abatement of twelve pharmaceuticals, including antibiotics and antivirals, in laboratory experiments representing the treatment steps of anaerobic storage of source-separated human urine, stabilization using partial and full nitrification under acclimatized and non-acclimatized conditions, and treatment of nitrified urine using powdered activated carbon (PAC). Two-month-long-term storage of urine was insufficient to substantially degrade the pharmaceuticals, except for hydrochlorothiazide (>90%). In the partial and full nitrification fed-batch reactors, atazanavir, ritonavir, and clarithromycin were rapidly removed, with biotransformation rate constants greater than 10 L g SS −1d−1. Darunavir, emtricitabine, trimethoprim, N4-acetylsulfamethoxazole, sulfamethoxazole, atenolol, diclofenac, and hydrochlorothiazide were degraded slowly, with biotransformation rate constants of < 1 L g SS −1d−1. With 200 mg PAC L−1, at least 90% of each investigated pharmaceutical was removed. Yeast estrogen screen tests and bioluminescence inhibition tests revealed efficient removal of estrogenicity (99%) and toxicity (56%) using nitrification, and a reduction of 89% and 64%, respectively, using 200 mg PAC L−1. With our study, we provide biotransformation rate constants of compounds never previously investigated. We also show that a combination of nitrification and PAC adsorption enables the production of a safe fertilizer with sufficiently low pharmaceutical concentrations and no removal of beneficial nutrients. Image, graphical abstract [ABSTRACT FROM AUTHOR]

In eThekwini, South Africa, the production of agricultural fertilizers from human urine collected from urine-diverting dry toilets is being evaluated at a municipality scale as a way to help finance a decentralized, dry sanitation system. The present study aimed to assess a range of human and environmental health hazards in source-separated urine, which was presumed to be contaminated with feces, by evaluating the presence of human pathogens, pharmaceuticals, and an antibiotic resistance gene. Composite urine samples from households enrolled in a urine collection trial were obtained from urine storage tanks installed in three regions of eThekwini. Polymerase chain reaction (PCR) assays targeted 9 viral and 10 bacterial human pathogens transmitted by the fecal–oral route. The most frequently detected viral pathogens were JC polyomavirus, rotavirus, and human adenovirus in 100%, 34% and 31% of samples, respectively. Aeromonas spp. and Shigella spp. were frequently detected gram negative bacteria, in 94% and 61% of samples, respectively. The gram positive bacterium, Clostridium perfringens , which is known to survive for extended times in urine, was found in 72% of samples. A screening of 41 trace organic compounds in the urine facilitated selection of 12 priority pharmaceuticals for further evaluation. The antibiotics sulfamethoxazole and trimethoprim, which are frequently prescribed as prophylaxis for HIV-positive patients, were detected in 95% and 85% of samples, reaching maximum concentrations of 6800 μg/L and 1280 μg/L, respectively. The antiretroviral drug emtricitabine was also detected in 40% of urine samples. A sulfonamide antibiotic resistance gene ( sul1 ) was detected in 100% of urine samples. By coupling analysis of pathogens and pharmaceuticals in geographically dispersed samples in eThekwini, this study reveals a range of human and environmental health hazards in urine intended for fertilizer production. Collection of urine offers the benefit of sequestering contaminants from environmental release and allows for targeted treatment of potential health hazards prior to agricultural application. The efficacy of pathogen and pharmaceutical inactivation, transformation or removal during urine nutrient recovery processes is thus briefly reviewed. [ABSTRACT FROM AUTHOR]